22 §2698-A. Marketing costs (REPEALED)
§2698-A. Marketing costs (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 688, §C8 (AMD). PL 2005, c. 286, §§1,2 (AMD). PL 2011, c. 461, §3 (RP).
22 §2698-B. Actual price disclosure and certification (REPEALED)
§2698-B. Actual price disclosure and certification (REPEALED) SECTION HISTORY PL 2003, c. 667, §1 (NEW). PL 2003, c. 667, §2 (AFF). PL 2005, c. 402, §§1-4 (AMD). PL 2011, c. 461, §4 (RP).
22 §2699. Prescription drug practices (REPEALED)
§2699. Prescription drug practices (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 430, §1 (NEW). PL 2003, c. 430, §3 (AFF). PL 2003, c. 456, §1 (NEW). PL 2003, c. 673, §§FFF1,2 (AMD). PL 2003, c. 688, §§C9,10 (AMD). PL 2003, c. 688, §C11 (AFF). […]
22 §2700. Unused Pharmaceutical Disposal Program
§2700. Unused Pharmaceutical Disposal Program 1. Establishment; purpose. There is established the Unused Pharmaceutical Disposal Program, referred to in this chapter as “the program.” The purpose of the program is to ensure the safe, effective and proper disposal of unused pharmaceuticals. For purposes of compliance with federal law and regulation, the return of pharmaceuticals under […]
22 §2700-A. Prohibitions
§2700-A. Prohibitions 1. Definitions. As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings. A. [PL 2011, c. 461, §5 (RP).] B. “Manufacturer of prescription drugs” or “manufacturer” means a manufacturer of prescription drugs or biological products or an affiliate of the manufacturer or a labeler that […]
22 §2668. Closure
§2668. Closure The department may close any public pool or spa for failure to comply with the provisions of this chapter. [PL 2007, c. 631, §10 (AMD).] Before closing a public pool or spa, the department shall issue a notice in writing enumerating instances of failure to comply with the law or rules. The […]
22 §2694. Rulemaking
§2694. Rulemaking With the exception of rules designated in this subchapter as major substantive rules, rules adopted pursuant to this subchapter are routine technical rules as defined by Title 5, chapter 375, subchapter II‑A. [PL 1999, c. 786, Pt. A, §3 (NEW).] SECTION HISTORY PL 1999, c. 786, §A3 (NEW).
22 §2669. Penalties
§2669. Penalties The department may seek injunctive or other appropriative judicial relief for violations of any provisions of this chapter. [PL 1985, c. 150 (NEW).] SECTION HISTORY PL 1985, c. 150 (NEW).
22 §2697. Profiteering in prescription drugs
§2697. Profiteering in prescription drugs Prescription drugs are a necessity of life. Profiteering in prescription drugs is unlawful and is subject to the provisions of this section. The provisions of this section apply to manufacturers, distributors and labelers of prescription drugs. [PL 1999, c. 786, Pt. A, §3 (NEW).] 1. Definitions. As used in […]
22 §2671. Definitions
§2671. Definitions As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings. [PL 2015, c. 418, §1 (NEW).] 1. Eligible patient. “Eligible patient” means a person who has: A. Received a diagnosis of a terminal illness for which no standard treatment is effective and the diagnosis […]